Amount Raised
$73 Million
Round Type
Series A
San FranciscoBiotechnologyHealth CareScience And EngineeringDescription
Walking Fish Therapeutics, a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising a total of $73 million. The additional investment, co-led by Northpond Ventures and First Spark Ventures, with support from Terra Magnum Capital Partners, will be used to advance a pipeline of B cell therapeutics for oncology, rare disease, regenerative medicine, autoimmune disease, and recombinant antibody production. Walking Fish Therapeutics made its debut in September 2021 with the launch of Series A financing led by Emerson Collective, Illumina Ventures, and Quan Capital. Daniel Janse, Ph.D
Quick answer
Walking Fish Therapeutics raised $73 Million in a Series A round, dated February 16, 2022. Walking Fish Therapeutics is based in San Francisco, California, United States.
- How much did Walking Fish Therapeutics raise?
- Walking Fish Therapeutics raised $73 Million in a Series A round on February 16, 2022.
- What does Walking Fish Therapeutics do?
- A leader in B cell medicines, Walking Fish Therapeutics has made critical advances in engineering technologies to rapidly advance cell-based therapeutics to treat serious diseases, concentrating on oncology, rare..
- Where is Walking Fish Therapeutics based and how big is it?
- Walking Fish Therapeutics is based in San Francisco, California, United States.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Walking Fish Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- 2seventy bio raised $170M on March 31, 2022.
- Zephyr AI, Inc. raised $19M (Seed) on March 30, 2022.
- Geneos Therapeutics raised $17M on March 28, 2022.
- Geneos Therapeutics raised $17M (Series A) on March 24, 2022.
- Nucleai raised $33M (Series B) on March 22, 2022.
- Theriva Biologics raised $1.5M (Seed) on March 21, 2022.
Who to call at Walking Fish Therapeutics, and when
A new round usually means Walking Fish Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Walking Fish Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Walking Fish Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Walking Fish Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Walking Fish Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansWalking Fish Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.